- Published on
Two categories of 'slimming injections' have clinical evidence: GLP-1 receptor agonists (semaglutide/Wegovy, tirzepatide/Mounjaro) for systemic weight loss, and deoxycholic acid (Belkyra/Kybella) for localised submental fat reduction. Their evidence bases, mechanisms, and regulatory status in the UK are reviewed here.